Compliance Rate

Compliance Rate 36.36%
Compliant submissions 8
Incompliant submissions 14
Total trials 22

My Organizations' Clinical Trials

Showing 550 of 1641 entries
View as:

Dual Inhibition of EGFR With Afatinib and Cetuximab in the Treatment of Advanced Squamous Cell Cancers of the Head and Neck

Phase: N/A Priority: Normal
NCT ID: NCT02979977 Org: User:
Start: 03/24/17 End: 01/31/26 Due: 01/31/27

APX005M With Nivolumab and Cabiralizumab in Advanced Melanoma, Non-small Cell Lung Cancer or Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT03502330 Org: User:
Start: 06/09/18 End: 05/15/24 Due: 05/15/25

High-Dose Topotecan and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002948 Org: User:
Start: 10/31/96 End: 01/31/04 Due: 01/31/05

HIV Risk Reduction and Drug Abuse Treatment in Malaysia

Phase: N/A Priority: Normal
NCT ID: NCT00383045 Org: User:
Start: 04/30/03 End: 08/31/07 Due: 08/31/08

Investigating the Impact of Self-monitoring Feedback for Health Behaviors

Phase: N/A Priority: Normal
NCT ID: NCT03940599 Org: User:
Start: 06/21/18 End: 08/31/18 Due: 08/31/19

Pilot for The Breast Cancer Endocrine Therapy Adherence (BETA) Trial

Phase: N/A Priority: Normal
NCT ID: NCT02256670 Org: User:
Start: 10/31/14 End: 08/31/16 Due: 08/31/17

Parametric Cardiac 18F-flutemetamol PET Imaging in ATTR Cardiomyopathy

Phase: N/A Priority: Normal
NCT ID: NCT05374564 Org: User:
Start: 08/16/22 End: 06/30/25 Due: 06/30/26

Evaluation of Weekly Ixabepilone With or Without Biweekly Bevacizumab

Phase: N/A Priority: Normal
NCT ID: NCT03093155 Org: User:
Start: 04/03/17 End: 12/29/22 Due: 12/29/23

Efficacy of Pimozide Augmentation for Clozapine Partial Response

Phase: N/A Priority: Normal
NCT ID: NCT00374244 Org: User:
Start: 01/31/04 End: 06/30/11 Due: 06/30/12

Naltrexone for Opioid Dependent Released Human Immunodeficiency Virus Positive (HIV+) Criminal Justice Populations

Phase: N/A Priority: Normal
NCT ID: NCT01246401 Org: User:
Start: 03/31/11 End: 07/31/16 Due: 07/31/17

Survey Experiment to Estimate Level of Mental Illness Stigma Based on Condition and Gender

Phase: N/A Priority: Normal
NCT ID: NCT06279962 Org: User:
Start: 06/15/23 End: 09/15/23 Due: 09/15/24

Computer Based Training in CBT in Primary Care

Phase: N/A Priority: Normal
NCT ID: NCT03013478 Org: User:
Start: 11/30/16 End: 08/31/18 Due: 08/31/19

Mindful Kala: Virtual Bharatanatyam Wellness Program for Students

Phase: N/A Priority: Normal
NCT ID: NCT04745364 Org: User:
Start: 02/04/21 End: 04/12/21 Due: 04/12/22

Preliminary Effectiveness of Remotely Monitored Blood Alcohol Concentration Device as Treatment Modality

Phase: N/A Priority: Normal
NCT ID: NCT04380116 Org: User:
Start: 06/29/20 End: 05/01/22 Due: 05/01/23

Using Video Modeled Social Stories to Improve Oral Hygiene in Children With Autism Spectrum Disorder

Phase: N/A Priority: Normal
NCT ID: NCT02003820 Org: User:
Start: 07/31/14 End: 07/31/15 Due: 07/31/16

The Gut-brain Axis: a Novel Target for Treating Behavioral Alterations in Obesity

Phase: N/A Priority: Normal
NCT ID: NCT01976156 Org: User:
Start: 10/31/13 End: 10/31/17 Due: 10/31/18

Effects of Enriched Parent-Infant Interaction on Health in Early Life

Phase: N/A Priority: Normal
NCT ID: NCT06248125 Org: User:
Start: 02/25/25 End: 06/30/26 Due: 06/30/27

Understanding Factors That Influence Electronic Cigarette Nicotine Delivery Through PET Imaging of Beta-2 Nicotinic Acetylcholine Receptors

Phase: N/A Priority: Normal
NCT ID: NCT04258852 Org: User:
Start: 12/30/22 End: 02/01/25 Due: 02/01/26

Ketamine/Placebo Family History Positive Study

Phase: N/A Priority: Normal
NCT ID: NCT00588952 Org: User:
Start: 03/31/01 End: 06/30/15 Due: 06/30/16

Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma

Phase: N/A Priority: Normal
NCT ID: NCT02166229 Org: User:
Start: 06/30/14 End: 08/31/14 Due: 08/31/15

Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients

Phase: N/A Priority: Normal
NCT ID: NCT05286242 Org: User:
Start: 02/10/21 End: 06/30/26 Due: 06/30/27

The Human Microbiome in Immune-Mediated Diseases

Phase: N/A Priority: Normal
NCT ID: NCT02394964 Org: User:
Start: 11/30/14 End: 12/31/23 Due: 12/31/24

Promoting Alcohol Treatment Engagement Post-hospitalization

Phase: N/A Priority: Normal
NCT ID: NCT05338151 Org: User:
Start: 09/13/22 End: 12/31/26 Due: 12/31/27

Stepped Care for Patients to Optimize Whole Recovery

Phase: N/A Priority: Normal
NCT ID: NCT05155163 Org: User:
Start: 06/28/23 End: 08/31/26 Due: 08/31/27

Safety and Efficacy of Oral TXA in Reducing Blood Loss and Transfusion in Hip Fractures

Phase: N/A Priority: Normal
NCT ID: NCT02908516 Org: User:
Start: 09/18/17 End: 12/15/17 Due: 12/15/18